相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High prevalence of anti-α-crystallin antibodies in multiple sclerosis: correlation with severity and activity of disease
M. A. Agius et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
CEREBROSPINAL FLUID MYELIN BASIC PROTEIN IMMUNOREACTIVITY AS AN INDICATOR OF BRAIN DAMAGE IN CHILDREN
S. D. Levin et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)
Soluble IL-2RA Levels in Multiple Sclerosis Subjects and the Effect of Soluble IL-2RA on Immune Responses
Lisa M. Maier et al.
JOURNAL OF IMMUNOLOGY (2009)
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
N. Mattsson et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis
Soheli A. Chowdhury et al.
ARCHIVES OF NEUROLOGY (2008)
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
Samantha Jilek et al.
BRAIN (2008)
Increased CSF-BACE 1 activity is associated with ApoE-ε4 genotype in subjects with mild cognitive impairment and Alzheimer's disease
Michael Ewers et al.
BRAIN (2008)
Recognition and degradation of myelin basic protein peptides by serum autoantibodies: Novel biomarker for multiple sclerosis
Alexey A. Belogurov et al.
JOURNAL OF IMMUNOLOGY (2008)
BRI2 (ITM2b) inhibits Aβ deposition in vivo
Jungsu Kim et al.
JOURNAL OF NEUROSCIENCE (2008)
Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis
K. Rejdak et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
May H. Han et al.
NATURE (2008)
Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults
H. Wang et al.
NEUROLOGY (2008)
Expression and regulation of IFNα/β receptor in IFNβ-treated patients with multiple sclerosis
F. Gilli et al.
NEUROLOGY (2008)
Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis
J. William Lindsey et al.
NEUROLOGY (2008)
Predictive markers for response to interferon therapy in patients with multiple sclerosis
S. Malucchi et al.
NEUROLOGY (2008)
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event
Jean-Christophe Corvol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis
Francisco J. Quintana et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
APOE ε4 allele is associated with cognitive impairment in patients with multiple sclerosis
J. Shi et al.
NEUROLOGY (2008)
Cerebrospinal fluid markers in Creutzfeldt-Jakob disease
Anders Skinningsrud et al.
FLUIDS AND BARRIERS OF THE CNS (2008)
Acute transverse myelitis with normal brain MRI - Long-term risk of MS
Jai Perumal et al.
JOURNAL OF NEUROLOGY (2008)
Amyloid Beta Protein and Tau in Cerebrospinal Fluid and Plasma as Biomarkers for Dementia: A Review of Recent Literature
Suzanne V. Frankfort et al.
CURRENT CLINICAL PHARMACOLOGY (2008)
Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of Multiple Sclerosis
M. Riverol et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Reduced effectiveness of long-term interferon-β treatment on relapses in neutralizing antibody-positive multiple sclerosis patients:: a Canadian multiple sclerosis clinic-based study
C. Boz et al.
MULTIPLE SCLEROSIS (2007)
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS
V. Tomassini et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders
D. J. Rigotti et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2007)
The incidence and significance of anti-natalizumab antibodies -: Results from AFFIRM and SENTINEL
P. A. Calabresi et al.
NEUROLOGY (2007)
Identification of interferon-beta antibodies in a reference laboratory setting: Findings for 1144 consecutive sera
Harry E. Prince et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
TRAIL, CXCL10 and CCL2 levels during long-term Interferon-β treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response
Mathias Buttmann et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis:: diagnostic and therapeutic implications
J. O. Virtanen et al.
JOURNAL OF NEUROVIROLOGY (2007)
Alteration of cystatin C in the cerebrospinal fluid of multiple sclerosis
Ichiro Nakashima et al.
ANNALS OF NEUROLOGY (2007)
Antibodies against light neurofilaments in multiple sclerosis patients
A. Bartos et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Cerebrospinal fluid proteome profile in multiple sclerosis
V. Lehmensiek et al.
MULTIPLE SCLEROSIS (2007)
Cystatin C in cerebrospinal fluid and multiple sclerosis
Sara F. Hansson et al.
ANNALS OF NEUROLOGY (2007)
Cleavage of cystatin C is not associated with multiple sclerosis
Piero Del Boccio et al.
ANNALS OF NEUROLOGY (2007)
Protective and therapeutic role for αB-crystallin in autoimmune demyelination
Shalina S. Ousman et al.
NATURE (2007)
Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein
Josef Marksteiner et al.
DRUGS OF TODAY (2007)
Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis
M. Terzi et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry
Bas Jasperse et al.
JOURNAL OF NEUROLOGY (2007)
The role of TRAIL/TRAIL receptors in central nervous system pathology
Orhan Aktas et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Extensive cortical remyelination in patients with chronic multiple sclerosis
Monika Albert et al.
BRAIN PATHOLOGY (2007)
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology
Roberta Magliozzi et al.
BRAIN (2007)
Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact: An evidence report - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
D. S. Goodin et al.
NEUROLOGY (2007)
High CSF neurofilament heavy chain levels in neuromyelitis optica
I. Miyazawa et al.
NEUROLOGY (2007)
Detection of anti-Nogo receptor autoantibody in the serum of multiple sclerosis and controls
H. Onoue et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions
Tanja Kuhlmann et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Interferon receptor expression in multiple sclerosis patients
Begona Oliver et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF
Jens Kuhle et al.
JOURNAL OF NEUROLOGY (2007)
Lack of association between antimyelin antibodies and progression to multiple sclerosis
Jens Kuhle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Antimyelin antibodies with no progression to multiple sclerosis
Raul Pelayo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis
Anna Jurewicz et al.
NEUROLOGY (2007)
Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis
Ales Bartos et al.
JOURNAL OF NEUROLOGY (2007)
Proteomic analysis of human activated by multiple sclerosis cerebral endothelial cells serum and IFNβ-1b
J. Steven Alexander et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2007)
Identification of molecular biomarkers for multiple sclerosis
Sallyanne C. Fossey et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Alberto Ascherio et al.
ANNALS OF NEUROLOGY (2007)
APOE genotypes in Greek multiple sclerosis patients: no effect on the MS Severity Score
Georgios Koutsis et al.
JOURNAL OF NEUROLOGY (2007)
Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations
S. J. Pittock et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Tetranectin in cerebrospinal fluid of patients with multiple sclerosis
B. Stoevring et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2006)
A new focal EAE model of cortical demyelination:: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination
Doron Merkler et al.
BRAIN (2006)
The value of animal models for drug development in multiple sclerosis
Manuel A. Friese et al.
BRAIN (2006)
Lumbar cerebrospinal fluid proteome in multiple sclerosis: Characterization by ultrafiltration, liquid chromatography, and mass spectrometry
Jean-Paul Noben et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Dynamics of interferon-β modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-β neutralizing antibodies
Roseane Santos et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
The impact of our genes: Consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis
Franz Fazekas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event
S Rauer et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
The CSF levels of total-tau and phosphotau in patients with relapsing-remitting multiple sclerosis
H Bartosik-Psujek et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis
PH Lalive et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis
DN Irani et al.
ANNALS OF NEUROLOGY (2006)
Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1
F Gilli et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis
J Guimaraes et al.
MULTIPLE SCLEROSIS (2006)
IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: Implications for their possible immunopathogenic roles
C. Malmestrom et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Multiple sclerosis: Advances in understanding, diagnosing, and treating the underlying disease
RJ Fox et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2006)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
M Krumbholz et al.
BRAIN (2006)
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution
M Rovaris et al.
NEUROLOGY (2005)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid β (Aβ) production
A Fotinopoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The importance of measuring IFNβ bioactivity:: Monitoring in MS patients and the effect of anti-IFNβ antibodies
AR Pachner et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
The familial dementia BRI2 gene binds the Alzheimer gene amyloid-β precursor protein and inhibits amyloid-β production
S Matsuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Expression pattern of NOGO-A protein in the human nervous system
A Buss et al.
ACTA NEUROPATHOLOGICA (2005)
Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis
ET Lim et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Up-regulation of osteopontin and αΒ-crystallin in the normal-appearing white matter of multiple sclerosis:: an immunohistochemical study utilizing tissue microarrays
C Sinclair et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients
H Bartosik-Psujek et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
A randomized clinical trial of valacyclovir in multiple sclerosis
JE Friedman et al.
MULTIPLE SCLEROSIS (2005)
Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis
J Brettschneider et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL
O Aktas et al.
NEURON (2005)
Transplantation of human neural stem cells for spinal cord injury in primates
A Iwanami et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis
F Gilli et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Plasma osteopontin levels in multiple sclerosis
M Comabella et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
B Serafini et al.
BRAIN PATHOLOGY (2004)
Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG
H Bartosik-Psujek et al.
JOURNAL OF NEUROLOGY (2004)
Accelerated evolution of brain atrophy and Black holes in MS patients with APOE-ε4
C Enzinger et al.
ANNALS OF NEUROLOGY (2004)
Influence of apolipoprotein E ε4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis
N De Stefano et al.
ARCHIVES OF NEUROLOGY (2004)
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis
R Magliozzi et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis
Y Kawamoto et al.
ACTA NEUROPATHOLOGICA (2004)
Neutralizing antibodies against IFN-β in multiple sclerosis:: antagonization of IFN-β mediated suppression of MMPs
F Gilli et al.
BRAIN (2004)
The 14-3-3 protein ε isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes
J Satoh et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Soluble interleukin-6 receptor (slL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases
M Michalopoulou et al.
IMMUNOLOGY LETTERS (2004)
Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients
D Dumont et al.
PROTEOMICS (2004)
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
N Norgren et al.
NEUROLOGY (2004)
Tau protein in cerebrospinal fluid:: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis
A Martínez-Yélamos et al.
NEUROSCIENCE LETTERS (2004)
Proteomic analysis of multiple sclerosis cerebrospinal fluid
BN Hammack et al.
MULTIPLE SCLEROSIS (2004)
Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients
MHJ Vogt et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis
G Savettieri et al.
JOURNAL OF NEUROLOGY (2004)
CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS
A Martínez-Yélamos et al.
JOURNAL OF NEUROLOGY (2004)
No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis
JNP Zwemmer et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis
B Zakrzewska-Pniewska et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Cerebrospinal fluid levels of brain specific proteins in optic neuritis
ET Lim et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
The 14-3-3 protein in multiple sclerosis: a marker of disease severity
M Colucci et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
Imaging neuronal and axonal degeneration in multiple sclerosis
N De Stefano et al.
NEUROLOGICAL SCIENCES (2003)
Anti-IFN BAb and NAb antibodies - A minireview
K Bendtzen
NEUROLOGY (2003)
The measurement of antibodies binding to IFNβ in MS patients treated with IFNβ
AR Pachner et al.
NEUROLOGY (2003)
Antibodies to myelin basic protein, myelin oligodendrocytes peptides, α-β-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis
A Vojdani et al.
JOURNAL OF INTERNAL MEDICINE (2003)
Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis
J Satoh et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event
T Berger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Subpial demyelination in the cerebral cortex of multiple sclerosis patients
L Bo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis
KP Wandinger et al.
LANCET (2003)
Elevated osteopontin levels in active relapsing-remitting multiple sclerosis
MHJ Vogt et al.
ANNALS OF NEUROLOGY (2003)
Amyloid beta 1-42, and tau in cerebrospinal fluid after severe traumatic brain injury
G Franz et al.
NEUROLOGY (2003)
Nitric oxide as an activity marker in multiple sclerosis
G Acar et al.
JOURNAL OF NEUROLOGY (2003)
Persistent neutralizing antibodies abolish the interferon β bioavailability in MS patients
A Bertolotto et al.
NEUROLOGY (2003)
Multiple sclerosis - Neurofilament light chain antibodies are correlated to cerebral atrophy
MJ Eikelenboom et al.
NEUROLOGY (2003)
Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders
M Reindl et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Blocking effects of serum reactive antibodies induced by glatiramer acetate treatment in multiple sclerosis
HH Salama et al.
BRAIN (2003)
Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein epsilon 4 allele
C Enzinger et al.
ARCHIVES OF NEUROLOGY (2003)
Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy
D Teitelbaum et al.
MULTIPLE SCLEROSIS JOURNAL (2003)
Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis
FJ Jiménez-Jiménez et al.
ACTA NEUROLOGICA SCANDINAVICA (2002)
Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels
V Calabrese et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Cerebrospinal fluid and serum protein levels of tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R gp80) in multiple sclerosis patients
A Vladic et al.
CYTOKINE (2002)
Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement:: Evidence for different clinical cohorts -: Initial observations
O Gonen et al.
RADIOLOGY (2002)
The role of nitric oxide in multiple sclerosis
KJ Smith et al.
LANCET NEUROLOGY (2002)
MR correlates of cerebral atrophy in patients with multiple sclerosis
N De Stefano et al.
JOURNAL OF NEUROLOGY (2002)
The clinico-radiological paradox in multiple sclerosis revisited
F Barkhof
CURRENT OPINION IN NEUROLOGY (2002)
Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells
JD Lünemann et al.
JOURNAL OF IMMUNOLOGY (2002)
Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit
E Silber et al.
NEUROLOGY (2002)
Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability
YK Semra et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
N-acetylaspartate is an axon-specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve
C Bjartmar et al.
ANNALS OF NEUROLOGY (2002)
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
D Chabas et al.
SCIENCE (2001)
Evaluation of bioavailability of three types of IFNβ in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification
A Bertolotto et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis
A Martínez-Yélamos et al.
NEUROLOGY (2001)
Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions
JSH Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone®
T Brenner et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Nitric oxide and blood-brain barrier integrity
VE Thiel et al.
ANTIOXIDANTS & REDOX SIGNALING (2001)
Anti-aαB-crystallin immunoreactivity in inflammatory nervous system diseases
B Çelet et al.
JOURNAL OF NEUROLOGY (2000)
Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1
MS Chen et al.
NATURE (2000)
Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein
T GrandPré et al.
NATURE (2000)
Neurobiology - Inhibitor of neurite outgrowth in humans
R Prinjha et al.
NATURE (2000)
In vitro expression of N-acetyl aspartate by oligodendrocytes: Implications for proton magnetic resonance spectroscopy signal in vivo
KK Bhakoo et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Increased cerebrospinal fluid tau protein in multiple sclerosis
E Kapaki et al.
EUROPEAN NEUROLOGY (2000)
分享论文
